Women of childbearing age there is evidence that prenatal exposure to the drug interferes greatly with concurrent fetal development
For weight management , semaglutide (Wegovy) is approved by the MHRA and has received a positive NICE technology appraisal recommendation for use in adults with obesity or overweight with weight-related comorbidities, subject to eligibility criteria
Bonus Tip: For maximum results, consume 1600-1800 calories per day, exercise 30-45 minutes each day, and stay hydrated
Front Immunol 2023;14:1148209.ArticlePubMedPMC 7
Decrease hunger Decrease food intake
For month-to-month plans, the initial consultation is $50, but subsequent months include one consultation (if needed), your custom treatment plan, medication, and delivery